|

Heart Disease Clinical Trials in Delaware

17 recruiting studies across 7 cities

All Trials in Delaware

Phase
Trial Phase Location
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3Dover
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Newark
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Newark
Left Ventricular Structural Predictors of Sudden Cardiac Death—Newark
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma—Wilmington
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3Wilmington
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3Wilmington
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Wilmington
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2Phase 3Wilmington
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease—Wilmington
Optimal Ventilation for Cardiac ArrestN/AWilmington
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—Wilmington
Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest—Wilmington
Quality of Pediatric Resuscitation in a Multicenter Collaborative—Wilmington
Tezspire Cardiac Events PASS—Wilmington
The Fourth Left Atrial Appendage Occlusion StudyN/AWilmington
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersPhase 3Wilmington

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.